External Contributer Articles of Labiotech.eu

About

Many authors are contributing to Labiotech.eu. If you want to join them, feel free to reach out to us with your article ideas.

Articles by External Contributor

News and Trends 19 Dec 2016

Why don’t more Biotech Startups Succeed? Merck might have a Solution

Merck is supporting startups with its Emerging Biotech Initiative, which grants winners up to €100K in products and services. As the number of R&D projects started by biotech companies and academic institutions increases, biotech is proving itself to be a vital part of medicine. So what’s holding startups back? Funding trouble is one of the […]

December 19, 2016 - 5 minutesmins - By External Contributor

News and Trends 14 Dec 2016

Liquid Biopsies: Lowering the Defenses of Resistant Lung Cancer

In response to new treatments, cancer came back stronger and more resistant than ever. Medicine’s counterattack will be more effective with a clear target. How do you solve a problem like drug resistance in cancer research? There’s no clear-cut answer yet, not least because the disease can vary so widely. But there has been some […]

December 14, 2016 - 4 minutesmins - By External Contributor

News and Trends 7 Dec 2016

Ask the Biotech Recruiter: Here are 7 Signs it’s Time to Talk to the Headhunters

Finding a new executive is never easy. Is it time to ask for help? The biotech headhunters at Pact & Partners can lend a hand! How long have you been looking to fill a top-level position at your company? Is it taking more time than expected, and are you stuck scratching your head? Are you […]

December 7, 2016 - 6 minutesmins - By External Contributor

News and Trends 23 Nov 2016

This Company joins a Tech Initiative to Repair the Heart with Stem Cells

Eppendorf joins a Horizon 2020 consortium to support bioreactor development for stem cell cultivation for heart attack patients. Stem cells have huge potential to treat or even cure a wide variety of medical conditions. Efforts to mitigate damage after a heart attack with stem cells are making a lot of progress. Researchers have successfully grown […]

November 23, 2016 - 4 minutesmins - By External Contributor

card reading fate psychic Miriam Doerr Martin Frommherz fi

News and Trends 17 Nov 2016

What’s in the Cards for a Biosimilar after it Launches

As legal frameworks and regulatory pathways for biosimilars are in evolving all around the world, how will they affect the future of biosimilars? A biosimilar is a biological medicine that is similar to another already authorized for use, and they enter the market after the end of the patent of a biological drug. Biosimilars are […]

November 17, 2016 - 5 minutesmins - By External Contributor

News and Trends 17 Nov 2016

Find Out what’s Hot in the Latin American Biotech scene

You’ve probably heard about BIO-Europe, but what about BIO Latin America? The Latin American counterpart to BIO-Europe, Biolatam, was a success last year: over 250 attending companies from 20 countries participated in 400 one-on-one partnering meetings. Now, Biolatam kicks off in San Juan, Puerto Rico, on November 29th. It will feature over 300 dealmakers representing pharma, biotech and the accompanying […]

November 17, 2016 - 4 minutesmins - By External Contributor

News and Trends 16 Nov 2016

Meet the CEO making the Next Generation of Gene Therapies Possible

How do you solve a problem like lentiviral vector infections? CEVEC has done it. We sat down with the CEO, Frank Ubags, to talk about his company’s success. The last few decades have not been kind to gene therapy companies, but the field seems to be on the edge of a renaissance with adenoviral vectors […]

November 16, 2016 - 6 minutesmins - By External Contributor

News and Trends 14 Nov 2016

Ask the Biotech Recruiter: Time-Saving Tricks to Reel in a New Hire

Time is of the essence in a recruitment. The biotech recruiters at Pact & Partners know how to manage it efficiently without missing anything! Hiring a top talent is an exhausting and time-consuming process, and it can be tempting to rush through it once you think you’ve found a match. But this attitude can create more […]

November 14, 2016 - 6 minutesmins - By External Contributor

News and Trends 3 Nov 2016

CEVEC is Revolutionizing Industrial Protein & Viral Vector Production

CEVEC just filed a Biologics Master File (BB-MF) to the FDA for its CAP technology, which outperforms all current standards in the production of gene therapy vectors and glycosylated human proteins. CEVEC is a Biotech with the mission of raising the industrial standard for the large-scale production of glycosylated proteins, viral vaccines and gene therapy […]

November 3, 2016 - 2 minutesmins - By External Contributor

News and Trends 1 Nov 2016

This Technology could Open Up a new 4th Generation of Therapeutic Antibodies

From everyday immunostaining to billion-euro therapies, antibodies have become essential in Biotech. Selecting the right antibodies that are as close to human as possible minimizes risks and can be the key to success, especially in medical applications. What goes into making the best therapeutic antibodies? To answer this question, we sat down with BIOTEM, an experienced provider of custom […]

November 1, 2016 - 5 minutesmins - By External Contributor

cells pipetting well plate cells Andrii Slonchak fi

News and Trends 26 Oct 2016

Biosimilars are all the rage, but how do they compare to Generics?

Biosimilars could be the future of the pharmaceutical industry, as the market could grow 10-fold in the next 5 years. But how do they differ from generic drugs? During the past decade, Europe saw the emergence of a new type of drug: biosimilars. The concept of a “similar biological medicinal product” was adopted in EU […]

October 26, 2016 - 5 minutesmins - By External Contributor

crystal ball forecasting wavebreakmedia fi

7 Considerations for Commercializing a New Drug

So you have exciting science, but do you know if it will be a commercial success? Ask the drug development and commercialization experts, who have turned the pharma analytics and consultancy industry on its head! We sat down with Mirador Analytics, to talk about bringing a drug from the clinic to the market. They are […]

October 25, 2016 - 6 minutesmins - By External Contributor

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us